Get to know Ayvakit better with 2 real example sentences.
Ayvakit in a sentence
Context around Ayvakit
- Average sentence length in these examples: 28 words
- Position in the sentence: 1 start, 0 middle, 1 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Ayvakit
- In this selection, "ayvakit" usually appears near the start of the sentence. The average example has 28 words, and this corpus slice is mostly made up of statements.
- Around the word, developing stand out and add context to how "ayvakit" is used.
- Recognizable usage signals include driven by ayvakit but total and is developing ayvakit for the. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "ayvakit" sits close to words such as aabb, aabria and aacha, which helps place it inside the broader word index.
Example types with ayvakit
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Blueprint Medicines' Q3 2023 earnings showed a 90% YoY increase in product sales driven by Ayvakit, but total revenue dipped. (20 words)
The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. (36 words)
The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. (36 words)
Blueprint Medicines' Q3 2023 earnings showed a 90% YoY increase in product sales driven by Ayvakit, but total revenue dipped. (20 words)
Example sentences (2)
Blueprint Medicines' Q3 2023 earnings showed a 90% YoY increase in product sales driven by Ayvakit, but total revenue dipped.
The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.